Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Plo

Showing results (21-30 of 124) with videos related to

Pageof 13
Sort By:
Haematologica|October 24, 2024
New approaches to standard of care in early-phase myeloproliferative neoplasms: can interferon-α alter the natural history of the disease?Florence Pasquier, Jean Pegliasco, Jean-Edouard Martin, et al.
Expert Review of Hematology|May 17, 2019
The role of the thrombopoietin receptor MPL in myeloproliferative neoplasms: recent findings and potential therapeutic applicationsWilliam Vainchenker, Isabelle Plo, Caroline Marty, et al.
Medecine Sciences : M/S|April 10, 2015
[Properties and biological roles of TET proteins during embryogenesis and in hematopoiesis]Emna Mahfoudhi, Lise Secardin, Laurianne Scourzic, et al.
The Journal of Biological Chemistry|July 10, 2002
Overexpression of the atypical protein kinase C zeta reduces topoisomerase II catalytic activity, cleavable complexes formation, and drug-induced cytotoxicity in monocytic U937 leukemia cellsIsabelle Plo, Hélène Hernandez, Glenda Kohlhagen, et al.
Molecular Cancer Research : MCR|March 19, 2017
Quantitative Proteome Heterogeneity in Myeloproliferative Neoplasm Subtypes and Association with <i>JAK2</i> Mutation StatusNuria Socoro-Yuste, Vladan P Čokić, Julie Mondet, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 21, 2007
Defects in XRCC4 and KU80 differentially affect the joining of distal nonhomologous endsJosée Guirouilh-Barbat, Emilie Rass, Isabelle Plo, et al.
Frontiers in Endocrinology|September 29, 2017
Genetic Alterations of the Thrombopoietin/MPL/JAK2 Axis Impacting MegakaryopoiesisIsabelle Plo, Christine Bellanné-Chantelot, Matthieu Mosca, et al.
Frontiers in Endocrinology|October 6, 2017
Identification of <i>MPL</i> R102P Mutation in Hereditary ThrombocytosisChristine Bellanné-Chantelot, Matthieu Mosca, Caroline Marty, et al.
Cancer Research|November 18, 2008
AKT1 inhibits homologous recombination by inducing cytoplasmic retention of BRCA1 and RAD51Isabelle Plo, Corentin Laulier, Laurent Gauthier, et al.
Nature Structural & Molecular Biology|July 28, 2009
Role of Mre11 in chromosomal nonhomologous end joining in mammalian cellsEmilie Rass, Anastazja Grabarz, Isabelle Plo, et al.
Pageof 13

Showing results (21-30 of 124) with videos related to

Sort By:
Pageof 13
Haematologica|October 24, 2024
New approaches to standard of care in early-phase myeloproliferative neoplasms: can interferon-α alter the natural history of the disease?Florence Pasquier, Jean Pegliasco, Jean-Edouard Martin, et al.
Expert Review of Hematology|May 17, 2019
The role of the thrombopoietin receptor MPL in myeloproliferative neoplasms: recent findings and potential therapeutic applicationsWilliam Vainchenker, Isabelle Plo, Caroline Marty, et al.
Medecine Sciences : M/S|April 10, 2015
[Properties and biological roles of TET proteins during embryogenesis and in hematopoiesis]Emna Mahfoudhi, Lise Secardin, Laurianne Scourzic, et al.
The Journal of Biological Chemistry|July 10, 2002
Overexpression of the atypical protein kinase C zeta reduces topoisomerase II catalytic activity, cleavable complexes formation, and drug-induced cytotoxicity in monocytic U937 leukemia cellsIsabelle Plo, Hélène Hernandez, Glenda Kohlhagen, et al.
Molecular Cancer Research : MCR|March 19, 2017
Quantitative Proteome Heterogeneity in Myeloproliferative Neoplasm Subtypes and Association with <i>JAK2</i> Mutation StatusNuria Socoro-Yuste, Vladan P Čokić, Julie Mondet, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 21, 2007
Defects in XRCC4 and KU80 differentially affect the joining of distal nonhomologous endsJosée Guirouilh-Barbat, Emilie Rass, Isabelle Plo, et al.
Frontiers in Endocrinology|September 29, 2017
Genetic Alterations of the Thrombopoietin/MPL/JAK2 Axis Impacting MegakaryopoiesisIsabelle Plo, Christine Bellanné-Chantelot, Matthieu Mosca, et al.
Frontiers in Endocrinology|October 6, 2017
Identification of <i>MPL</i> R102P Mutation in Hereditary ThrombocytosisChristine Bellanné-Chantelot, Matthieu Mosca, Caroline Marty, et al.
Cancer Research|November 18, 2008
AKT1 inhibits homologous recombination by inducing cytoplasmic retention of BRCA1 and RAD51Isabelle Plo, Corentin Laulier, Laurent Gauthier, et al.
Nature Structural & Molecular Biology|July 28, 2009
Role of Mre11 in chromosomal nonhomologous end joining in mammalian cellsEmilie Rass, Anastazja Grabarz, Isabelle Plo, et al.
Pageof 13